La Jolla Pharmaceutical Company

The recent US Food and Drug Administration “expert roundtable” on talc may encourage a more complete move away from the use of the product as a pharmaceutical excipient, but also suggests challenges a

The recent US Food and Drug Administration “expert roundtable” on talc may encourage a more complete move away from the use of the product as a pharmaceutical excipient, but also suggests challenges a

Theravance Biopharma Inc. will eliminate debt from its balance sheet and improve its cash balance through the sale of its interest in Theravance Respiratory Company LLC (TRC) – representing an 85% sh

Innoviva, Inc. continues to branch out from collecting royalties on inhaled respiratory medicines commercialized by GlaxoSmithKline Pharmaceuticals Ltd. to a company also developing and commerciali